WallStreetZenWallStreetZen

NASDAQ: REVB
Revelation Biosciences Inc Stock Ownership - Who owns Revelation Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Revelation Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James RolkeChief Executive Officer2026-04-3010,115$1.13
$11.43kSell
Chester Stanley Zygmont IiiChief Financial Officer2026-04-3013,285$1.10
$14.61kSell
Chester Stanley Zygmont IiiChief Financial Officer2026-02-0413,100$1.65
$21.62kSell
James RolkeChief Executive Officer2026-02-038,521$1.86
$15.85kSell
Jennifer CarverDirector2026-02-031,661$1.87
$3.11kSell
Lakhmir S. ChawlaDirector2026-02-032,261$1.85
$4.18kSell
Jess RoperDirector2026-02-031,591$1.85
$2.94kSell
James RolkeChief Executive Officer2026-01-08532,829$0.90
$479.55kBuy
Lakhmir S. ChawlaDirector2026-01-0841,981$0.90
$37.78kBuy
Jess RoperDirector2026-01-0841,981$0.90
$37.78kBuy

1 of 2

REVB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when REVB insiders and whales buy or sell their stock.

REVB Shareholders

What type of owners hold Revelation Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Axa IM Prime Impact Master Fund I Sca Sicavraif52.65%1,958,984$2.21MInsider
Sean H. Fitzpatrick47.56%1,769,538$2.00MInsider
Andreas Typaldos47.56%1,769,538$2.00MInsider
George F. Tidmarsh40.95%1,523,422$1.72MInsider
Lawrence Feis20.06%746,491$843.53kInsider
Sabby Management LLC16.28%605,702$684.44kInstitution
Armistice Capital LLC11.67%434,272$490.73kInstitution
Glazer Capital LLC10.24%381,106$430.65kInsider
James Rolke5.83%216,882$245.08kInsider
Chester Stanley Zygmont Iii2.53%94,211$106.46kInsider

1 of 3

REVB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
REVB12.58%87.42%Net BuyingNet Selling
AIM1.03%98.97%Net BuyingNet Buying
ALZN0.69%99.31%Net BuyingNet Buying
AZTR1.39%98.08%
SXTP1.48%98.52%Net Buying
View Top Biotech Stocks

Revelation Biosciences Stock Ownership FAQ

Who owns Revelation Biosciences?

Revelation Biosciences (NASDAQ: REVB) is owned by 33.09% institutional shareholders, 230.03% Revelation Biosciences insiders, and 0.00% retail investors. Axa IM Prime Impact Master Fund I Sca Sicavraif is the largest individual Revelation Biosciences shareholder, owning 1.96M shares representing 52.65% of the company. Axa IM Prime Impact Master Fund I Sca Sicavraif's Revelation Biosciences shares are currently valued at $2.19M.

If you're new to stock investing, here's how to buy Revelation Biosciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.